Skip to main content
SpringerLink
Log in

Dry Eye

  • Chapter
Book cover Ocular Surface Disease Medical and Surgical Management

  • 781 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 1995; 223:555–8.

    Article  Google Scholar 

  2. Lemp MA: Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 1995; 21: 221–232.

    CAS  PubMed  Google Scholar 

  3. Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998; 17:38–56.

    Article  CAS  PubMed  Google Scholar 

  4. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: The interaction between ocular surface and lacrimal glands. Cornea 1998; 17:584–589.

    Article  CAS  PubMed  Google Scholar 

  5. Afonso AA, Monroy D, Stern ME, et al. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology 1999; 106:803–10.

    Article  CAS  PubMed  Google Scholar 

  6. Koffler BH, Lemp MA. The effect of an antihistamine (chlorpheniramine maleate) on tear production in humans. Am Ophthalmol 1980; 12:217.

    Google Scholar 

  7. Mader TH, Stulting RD. Keratoconjunctivitis sicca caused by diphenoxylate hydrochloride with atropine sulfate (Lomotil) [letter]. Am J Ophthalmol 1991; 111:377–378.

    CAS  PubMed  Google Scholar 

  8. Norn MS. Desiccation of the precorneal film. II. Permanent discontinuity and dellen. Acta Ophthalmol (Copenh) 1969; 47:881–9.

    Article  CAS  Google Scholar 

  9. Lemp MA, Holly FJ. Recent advances in ocular surface chemistry. Am J Optom Arch Am Acad Optom 1970; 47:669–72.

    CAS  PubMed  Google Scholar 

  10. Mengher LS, Bron AJ, Tonge SR, Gilbert DJ. A noninvasive instrument for clinical assessment of pre-corneal tear film stability. Curr Eye Res 1985; 4:1–7.

    CAS  PubMed  Google Scholar 

  11. Madden RK, Paugh JR, Wang C. Comparative study of two non-invasive tear film stability techniques. Curr Eye Res 1994; 13:263–269.

    CAS  PubMed  Google Scholar 

  12. Liu Z, Pflugfelder SC. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999; 106:939–943.

    Article  CAS  PubMed  Google Scholar 

  13. Mengher LS, Bron AJ, Tonge SR, Gilbert DJ. Effect of fluorescein instillation on the pre-corneal tear film stability. Curr Eye Res 1985; 4:9–12.

    CAS  PubMed  Google Scholar 

  14. Lemp MA, Dohlman CH, Kuwabara T et al. Dry eye secondary to mucous deficiency. Trans Am Acad Ophthalmol Otolaryngol 1971; 75:1223–1227.

    CAS  PubMed  Google Scholar 

  15. McCulley JP, Sciallis GF: Meibomian keratoconjunctivitis. Am J Ophthalmol 1977; 84:788–93.

    CAS  PubMed  Google Scholar 

  16. Zengin N, Tol H, Gunduz K et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea 1995; 14:144–6.

    CAS  PubMed  Google Scholar 

  17. Paschides CA, Kitsios G, Karakostas KX. Evaluation of tear break-up time, Schirmer’s-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol 1989; 7:155–7.

    CAS  PubMed  Google Scholar 

  18. Prabhasawat P, Tseng SC. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol 1998; 82:666–75.

    CAS  PubMed  Google Scholar 

  19. Xu KP, Tsubota K. Correlation of tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol 1995; 79:1042–9.

    CAS  PubMed  Google Scholar 

  20. Macri A, Rolando M, Pflugfelder SC. A standardized visual scale for evaluation of tear fluorescein clearance. Ophthalmology 2000; 107:1338–1343.

    Article  CAS  PubMed  Google Scholar 

  21. Macri A, Pflugfelder SC. Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol 2000; 118: 1632–1638.

    CAS  PubMed  Google Scholar 

  22. Von Bahr G. Konnte der Flussigkeitsabgang durch die cornea von physiologischer bedengtung sein. Acta Ophthalmol (Copenh) 1941; 19:125–134.

    Google Scholar 

  23. Gilbard JP, Farris RL, Santamaria II J. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol 1978; 96:677–681.

    CAS  PubMed  Google Scholar 

  24. Schirmer O. Studien zur Physiologie und Pathologie der Tränenabsonderdung und Tränenabfuhr. Graefes Arch Clin Exp Ophthalmol 1903; 56:197.

    Google Scholar 

  25. Van Bijsterveld OP. Diagnostic tests in sicca syndrome. Arch Ophthalmol 1969; 82:10–14.

    PubMed  Google Scholar 

  26. Jones LT. The lacrimal secretory system and its treatment. Am J Ophthalmol 1966; 62:47–60.

    CAS  PubMed  Google Scholar 

  27. Clinch TE, Benedetto DA, Felberg NT, Laibson PR. Schirmer’s test: a closer look. Arch Ophthalmol 1983; 101: 1383–6.

    CAS  PubMed  Google Scholar 

  28. Dursun D, Monroy D, Knighton R, et al. The effects of experimental tear removal on corneal surface regularity and barrier function. Ophthalmology 2000; 107:1754–60.

    Article  CAS  PubMed  Google Scholar 

  29. Feenstra RP, Tseng SCG. Comparison of fluorescein and rose bengal staining. Ophthalmology 1992; 99:605–17.

    CAS  PubMed  Google Scholar 

  30. Norn MS. Vital staining of the cornea and conjunctiva; with a mixture of fluorescein and rose bengal. Am J Ophthalmol 1967; 64:1078–80.

    CAS  PubMed  Google Scholar 

  31. Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea 1993; 12:366–7.

    CAS  PubMed  Google Scholar 

  32. Sjögren HS. Zur kenntnis der keratoconjunctivitis sicca (keratitis folliformis bei hypofunktion der tranendrusen) Acta Ophthalmol (Copenh) 1933; 11:1–151.

    Google Scholar 

  33. Norn MS. Lissamine green. Vital staining of cornea and conjunctiva. Acta Ophthalmol (Copenh) 1973; 51:483–91.

    CAS  Google Scholar 

  34. Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol 1991; 111:106–8.

    CAS  PubMed  Google Scholar 

  35. Robinson CP, Brayer J, Yamachika S, et al. Transfer of human serum IgG to non-obese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren’s Syndrome. Proc Natl Acad Sci USA 1998; 95:7538–43.

    Article  CAS  PubMed  Google Scholar 

  36. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren’s Syndrome. Arthritis Rheum 2000; 43:1647–54.

    Article  CAS  PubMed  Google Scholar 

  37. Pflugfelder SC, Whitcher JP, Daniels T. Sjögren’s Syndrome. In Pepose J, Holland G, Wilhelmus K, editors: Ocular infection and immunity, Mosby, St. Louis, 1996, pp. 1043–1047.

    Google Scholar 

  38. Gutgesell VJ, Stern GA, Hood GI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol 1982; 94:383–7.

    CAS  PubMed  Google Scholar 

  39. Jester JV, Nicolaides N, Kiss-Palvolgyi I, Smith RE. Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci 1989; 30:936–45.

    CAS  PubMed  Google Scholar 

  40. Heigle TJ, Pflugfelder SC. Aqueous tear production in patients with neurotrophic keratitis. Cornea 1996; 15:135–138.

    CAS  PubMed  Google Scholar 

  41. Afonso A, Sobrin L, Monroy DC, et al. Tear fluid gelatinase B activity correlates with tear IL-1α concentration and fluorescein tear clearance. Invest Ophthalmol Vis Sci 1999; 40:2506–12.

    CAS  PubMed  Google Scholar 

  42. Sand BB, Marner K, Norn MS. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial. Acta Ophthalmol (Copenh) 1989; 67:181–183.

    Article  CAS  Google Scholar 

  43. Laroche L, Arrata M, Brasseur G, Lagoutte F, Le Mer Y, Lumbroso P, Mercante M, Normand F, Rigal D, Roncin S. Treatment of dry eye syndrome with lacrimal gel: a randomized multicenter study. J Fr Ophthalmol 1991; 14:321–326.

    CAS  Google Scholar 

  44. Solomon A, Merin S. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca. J Ocul Pharmacol Ther 1998; 14:497–504.

    Article  CAS  PubMed  Google Scholar 

  45. Toda I, Shinozaki N, Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren’s Syndrome. Cornea 1996; 15:120–8.

    CAS  PubMed  Google Scholar 

  46. Murube J, Murube A, Chen A. Classification of artificial tears. II. Additives and commercial formulas. Adv Exp Med Bio 1998; 438:705–715.

    CAS  Google Scholar 

  47. Nelson JD, Farris RL. Sodium hyaluronate and polyvinyl artificial tear preparations: a comparison on patients with keratoconjunctivitis sicca. Arch Ophthalmol 1988; 106:484–487.

    CAS  PubMed  Google Scholar 

  48. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol, 1977; 22:69–87.

    Article  CAS  PubMed  Google Scholar 

  49. Pfister RR, Burstein N. The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest Ophthalmol 1976; 15:246–259.

    CAS  PubMed  Google Scholar 

  50. Adams J, Wilcox MJ, Trousdale MD, Chien DS, Shimizu RW. Morphologic and physiologic effects of artificial tear formulations on corneal epithelial derived cells. Cornea 1992; 11:234–241.

    CAS  PubMed  Google Scholar 

  51. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984; 27:459–461.

    CAS  PubMed  Google Scholar 

  52. Kono I, Kono K, Narushima K, Akama T, Suzuki H, Yamane K, Kashiwagi H. Beneficial effect of the local application of plasma fibronectin and autologous serum in patients with the keratoconjunctivitis sicca of Sjögren’s syndrome. Ryumachi 1986; 26:339–343.

    CAS  PubMed  Google Scholar 

  53. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S. Treatment of dry eye by autologous serum application in Sjögren’s syndrome [see comments]. Br J Ophthalmol 1999; 83:390–395.

    CAS  PubMed  Google Scholar 

  54. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000; 25:1101–1103.

    Article  CAS  PubMed  Google Scholar 

  55. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren’s syndrome. Ophthalmology 1999; 106:811–816.

    Article  CAS  PubMed  Google Scholar 

  56. Laibovitz RA, Solch S, Andriano K, O’Connell M, Silverman MH. Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca. Cornea 1993; 12:315–323.

    CAS  PubMed  Google Scholar 

  57. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 2000; 107:967–974.

    Article  CAS  PubMed  Google Scholar 

  58. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107:631–639.

    Article  CAS  PubMed  Google Scholar 

  59. Kunert KS, Tisdale AS, Stern ME, et al. Analysis of topical cyclosporin treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000; 118:1489–96.

    CAS  PubMed  Google Scholar 

  60. Turner K, Pflugfelder SC, Ji Z, et al. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporin ophthalmic emulsion. Cornea 2000; 19:492–6.

    Article  CAS  PubMed  Google Scholar 

  61. Shapiro L, Houri Y, Barak V, Soskolne WA, Halabi A, Stabholz A. Tetracycline inhibits porphyromonas gingivalis lipopolysaccharide lesions in vivo and TNF alpha processing in vitro. J Periodontal Res 1997; 32:183–188.

    Google Scholar 

  62. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991; 2:297–322.

    CAS  PubMed  Google Scholar 

  63. Golub LM, Sorsa T, Lee HM, Ciancio S, Sorbi D, Ramamurthy NS, Gruber B, Salo T, Konttinen YT. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis. J Clin Periodontol 1995; 22: 100–109.

    Article  CAS  PubMed  Google Scholar 

  64. Solomon A, Rosenblatt M, Li DQ, et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci 2000; 41:2544–57.

    CAS  PubMed  Google Scholar 

  65. Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial cell culture supernatant. Invest Ophthalmol Vis Sci 2000; 41:1703–9.

    CAS  PubMed  Google Scholar 

  66. Greenwald RA. Treatment of destructive arthritic disorders with MMP inhibitors: Potential role of tetracyclines. Ann NY Acad Sci 1994; 732:181–198.

    CAS  PubMed  Google Scholar 

  67. Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 1993; 116:88–92.

    CAS  PubMed  Google Scholar 

  68. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology 1997; 104:1863–1867.

    CAS  PubMed  Google Scholar 

  69. Hope-Ross MW, Chell PB, Kervick GN, McDonnell PJ, Jones HS. Oral tetracycline in the treatment of recurrent corneal erosions. Eye 1994; 8(Pt 4):384–388.

    PubMed  Google Scholar 

  70. Culbertson WW, Huang AJ, Mandelbaum SH, Pflugfelder SC, Boozalis GT, Miller D. Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology 1993; 100:1358–1366.

    CAS  PubMed  Google Scholar 

  71. Nelson JD, Friedlaender M, Yeatts RP, et al. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren’s Syndrome. The MGI Pharma Sjögren’s Syndrome study group. Adv Exp Med Biol 1998; 438:979–83.

    CAS  PubMed  Google Scholar 

  72. Fox RI, Stern M, Michelson P. Update on Sjögren’s Syndrome. Curr Opin Rheumatol 2000; 12:391–8.

    Article  CAS  PubMed  Google Scholar 

  73. Jumblatt JE, Jumblatt MM. Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. Exp Eye Res 1998; 67:341–6.

    Article  CAS  PubMed  Google Scholar 

  74. Hoyasa K, Veda H, Kim KJ, et al. Nucleotide stimulation of Cl(−) secretion in the pigmented rabbit conjunctiva. J Pharmacol Exp Ther 1999; 291:53–9.

    Google Scholar 

  75. Beetham WP. Filamentary keratitis. Trans Am Ophthalmol Soc 1936; 33:413–416.

    Google Scholar 

  76. Freeman JM. Punctal plug: evaluation of a new treatment for dry eye. Trans Am Acad Ophthalmol 1975; 79:874–76.

    Google Scholar 

  77. Dohlman DH. Punctal occlusion in keratoconjunctivitis sicca. Ophthalmology 1978; 85:1277–81.

    CAS  PubMed  Google Scholar 

  78. Tuberville AW, Frederick WR, Wood P. Punctal occlusion in tear deficiency syndromes. Ophthalmology 1982; 89:1170–1172.

    CAS  PubMed  Google Scholar 

  79. Willis RM, Folberg R, Krackmer JH, Holland EJ. The treatment of aqueous-deficient dry eye with removable punctal plugs: a clinical and impression cytology study. Ophthalmology 1987; 84:514–518.

    Google Scholar 

  80. Yang HY, Fujishima H, Toda I, Shimazaki J, Tsubota K. Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol 1997; 124: 80–7.

    CAS  PubMed  Google Scholar 

  81. Gusek-Schneider GC, Erbguth F. Protective ptosis by botulinum A toxin injection in corneal affectations. Klin Monatsbl Augenheilkd 1998; 213:15–22.

    Article  CAS  PubMed  Google Scholar 

  82. Wuebbolt GE, Drummond G. Temporary tarsorrhaphy induced with type A botulinum toxin. Can J Ophthalmol 1991; 26:383–5.

    CAS  PubMed  Google Scholar 

  83. Kirkness CM, Adams GG, Dilly PN, Lee JP. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 1988; 95:473–80.

    CAS  PubMed  Google Scholar 

  84. Murube J, Marcos MG, Javate R. Amylase in mare lacrimale in patients with submandibular salivary gland transplantation to the lacrimal basin. Adv Exp Med Biol 1994; 350:565–570.

    CAS  PubMed  Google Scholar 

  85. Geerling G, Sieg P, Bastian GO, Laqua H. Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca. Ophthalmology 1998; 105:327–35.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Stephen C. Pflugfelder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abraham Solomon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Pflugfelder, S.C., Solomon, A. (2002). Dry Eye. In: Ocular Surface Disease Medical and Surgical Management. Springer, New York, NY. https://doi.org/10.1007/0-387-21570-0_4

Download citation

  • DOI: https://doi.org/10.1007/0-387-21570-0_4

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95161-4

  • Online ISBN: 978-0-387-21570-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation